fda category 2 bulk drug substances bpc-157 list Peptide Reclassification 2026: What It Means for Providers FDA Adds Several Peptides to
Description
Lab Markers: Progress is monitored with lab work at baseline, 3 months, 6 months, and 12 months
That's because these treatments don't address root-cause biology
Mor, Margaret I., and David Kenley
It appears to stimulate the formation of granulation tissue, reepithelialization, and collagen depositionkey phases in the healing process
